Dayton Clinical Oncology Program | Dayton, OH

Research site

Location

6480 Centerville Business Parkway, Dayton, Ohio, United States of America

Website

https://daytonncorp.org/index.html

Site insights

Top conditions

Top treatments

Bevacizumab

Paclitaxel

Carboplatin

Dexamethasone

Trastuzumab

Cyclophosphamide

Lenalidomide

Doxorubicin Hydrochloride

Cisplatin

Everolimus

Parent organization

This site is a part of Dayton Clinical Oncology Program

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Amy Dempe

Verified by this site

Active trials

2 of 89 total trials

S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer

The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen depriva...

Active, not recruiting

Prostate Cancer

Drug: Bicalutamide

Drug: TAK-700

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling (FB-12)

This is a prospective, single arm, open label, multicenter interventional study designed to evaluate the efficacy of neoadjuvant chemotherapy with an...

Enrolling

HER2-negative Breast Cancer

Drug: Doxorubicin

Drug: Cyclophosphamide